Clinical test may predict best rheumatoid arthritis biologic for each individual

Researchers at Queen Mary, University of London, have developed a machine-learning test that predicts the optimal biologic therapy for rheumatoid arthritis patients with 79-85% accuracy. This innovation could revolutionise treatment by directly targeting specific disease mechanisms, potentially reducing patient suffering and avoiding ineffective treatments that compromise the immune system.